Skip to main content
Publications
Rousculp MD, Hollis K Ziemiecki R Odom D Odak S Jackson L Reactogenicity differences between adjuvanted, protein-based and messenger ribonucleic acid (mRNA)-based COVID-19 vaccines
Craig T, Baptist A, Anderson J, Zaragoza-Urdaz R, Burnette A, Kelbel T, Riedl M, Vanegas A Boyle K Patient-reported outcomes among patients with hereditary angioedema within underrepresented racial or ethnic groups
Dolin P, Kielar D, Shavit A, Koegh K, Rowell J, Edmonds C, Meyers J Esterberg E Nham T Comorbidities in patients with eosinophilic granulomatosis with polyangiitis versus severe uncontrolled asthma: a retrospective analysis of US health insurance claims data
Dolin P, Kielar D, Shavit A, Keogh K, Rowell J, Edmonds C, Meyers J Esterberg L Nham T Healthcare resource utilization and costs in patients with eosinophilic granulomatosis with polyangiitis versus severe uncontrolled asthma: a retrospective analysis of US health insurance claims data
Shamarina D, Sluga-O'Callaghan M Davenport E Knowledge, attitudes, and practices of European healthcare professionals towards hepatitis A and hepatitis B vaccination in at-risk adults
Burte E, Leynaert B, Marcon A, Bousquet J, Benmerad M, Bono R, Carsin AE Long-term air pollution exposure is associated with increased severity of rhinitis in 2 European cohorts 10.1016/j.jaci.2019.11.040
Guerra S, Melen E, Sunyer J, Xu CJ, Lavi I, Benet M, Bustamante M, Carsin AE Genetic and epigenetic regulation of YKL-40 in childhood 10.1016/j.jaci.2017.06.030
Mercieca-Bebber R, Rouette J, Calvert M, King MT, McLeod L Preliminary evidence on the uptake, use, and benefits of the CONSORT-PRO extension 10.1007/s11136-017-1508-6
Iribarren C, Rahmaoui A, Long AA, Szefler SJ, Bradley MS, Carrigan G, Eisner MD, Chen H, Omachi TA, Farkouh ME, Rothman KJ Cardiovascular and cerebrovascular events among patients receiving omalizumab: results from EXCELS, a prospective cohort study of moderate-to-severe asthma 10.1016/j.jaci.2016.07.038.
White MV, Silvia S, Hollis K Goss D Odom D Bartsch J EPIPEN4SCHOOLS® survey combined analysis: prevalence and triggers of anaphylactic events
Luquiens A, Whalley D Crawford SR Doward L Price M Development of the Alcohol Quality of Life Scale (AQoLS): a new patient-reported outcome measure to assess health-related quality of life in alcohol use disorder 10.1007/s11136-014-0865-7
Wooddell M, Goss DS Hollis KA Epinephrine administration for cases of anaphylaxis in a US school setting: results from the EpiPen4Schools survey
Gascon M, Casas M, Morales E, Valvi D, Ballesteros-Gomez A, Luque N, Rubio S, Monfort N, Ventura R, Martinez D Prenatal exposure to bisphenol A and phthalates and childhood respiratory tract infections and allergy 10.1016/j.jaci.2014.09.030
White MV, Goss D Hollis K EpiPen4Schools® survey: characteristics of anaphylaxis and common triggers
Hogue SL, Bennett ME, Goss DS Hollis KA Occurrence of anaphylaxis by school grade level and staff training: findings from the EpiPen4Schools survey
White MV, Goss DS Hollis KA EpiPen4Schools survey: characteristics of anaphylaxis and common triggers
Reeve BB, Wyrwich KW, Wu AW, Velikova G, Terwee CB, Snyder CF, Schwartz C, Revicki DA, Moinpour CM, McLeod LD ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research 10.1007/s11136-012-0344-y
